Immunotherapy Drugs Causing Vision Issues – Asbestos.com
Asbestos.com |
Immunotherapy Drugs Causing Vision Issues
Asbestos.com The U.S. Food and Drug Administration (FDA) is investigating the potential for three immunotherapy drugs to cause retinal detachment and vision loss. The FDA will consider adding eye toxicities to the warning labels for pembrolizumab (Keytruda … |
